In contrast to the above-mentioned biomarkers, we relate to low ALT levels as a reliable representative of sarcopenia and frailty, while hemoglobin and albumin levels should be related to as biomarkers for the temporal nutritional status of patients rather than reflecting their status of sarcopenia and frailty. This evidence concerns the gene ALB and sarcopenia.